Access cutting-edge pancreatic cancer treatment through this early phase 1 clinical trial at a research site in New Hyde Park. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this New Hyde Park location
Preparing your pre-screening questions…
Access pancreatic cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related pancreatic cancer treatment provided free
Check if you qualify for this pancreatic cancer clinical trial in New Hyde Park, NY
No-Cost Study Care
Local to New Hyde Park
Convenient for NY residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Predicting drug response offers an opportunity to improve cancer treatment delivery. Recently, microdevices were invented to ascertain in vivo drug response but have not yet been evaluated for pancreatic cancer. This study is a prospective phase 1 safety study of intraoperative placement and retrieval of a microdevice in patients with pancreatic cancer. The devices will be implanted intra-operatively and removed en-bloc with the tumor after a 4- hour incubation period. Patients will be monitored to ensure that the placement and retrieval of these devices does not increase complication rates within one month of surgery. To assess feasibility, the tissue surrounding the microdevices is then analyzed to determine the diffusion of drugs from the device(s) to surrounding tissue, and whether the chemotherapeutic effect of diffusing chemotherapy drug has an impact on the surrounding tissue. In an exploratory analysis, material from the patient's tumors will be grown into organoids and drug response correlation from organoids will be compared to the response observed from the microdevices.
Sponsor: Northwell Health
Yes, this clinical trial (NCT07254091) has an active research site in New Hyde Park, NY that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for pancreatic cancer treatment options in New Hyde Park, NY, this clinical trial (NCT07254091) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New Hyde Park research site is actively enrolling participants for this early phase 1 clinical trial. You'll receive care from experienced pancreatic cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all pancreatic cancer clinical trials near you to find additional studies recruiting in your area.
See all pancreatic cancer clinical trials recruiting in New Hyde Park — not just this study.
Browse Pancreatic Cancer Trials in New Hyde Park →